Axiata, Revenue Group, Jerasia and TMC Life Sciences

Axiata, Revenue Group, Jerasia and TMC Life Sciences

KUALA LUMPUR (Feb 9): Based on corporate announcements and news flow on Wednesday (Feb 9), companies that may be in focus on Thursday include Axiata Group Bhd, Revenue Group Bhd, Jerasia Capital Bhd and TMC Life Sciences Bhd.

The shareholder dispute on the divestment of Axiata Group Bhd’s subsidiary Celcom Axiata Bhd’s 35% stake in Tune Talk Sdn Bhd has been brought to the Asian International Arbitration Centre (AIAC). A group of Tune Talk shareholders, who collectively hold a 30.02% stake, is trying to block Celcom Axiata from selling its 35% stake in the mobile virtual network operator.

Revenue Group Bhd is slated to transfer to the Main Market of Bursa Malaysia from the ACE Market on Feb 14. The electronic payments firm said its entire share capital of 466.23 million shares, together with 156.628 million warrants, will be transferred to the Main Market. Its stock short name, stock code and international securities identification number code will remain unchanged.

PN17 company Jerasia Capital Bhd said three of its wholly-owned subsidiaries — Canteran Apparel Sdn Bhd, Jerasia Fashion Sdn Bhd and Jerasia Apparel Sdn Bhd — have defaulted in their repayment of principal and interest of financing facilities granted by United Overseas Bank (Malaysia) Bhd, totalling RM74.62 million.

TMC Life Sciences Bhd’s net profit grew 27.85% to RM6.91 million for the second quarter ended Dec 31, 2021, from RM5.4 million a year prior, on the back of its quarterly revenue rising 21.36% to RM59.22 million from RM48.79 million.

https://www.theedgemarkets.com/article/axiata-revenue-group-jerasia-tmc-life-sciences-and-systematization